BR0303500A - Anticorpo monoclonal especìfico para um epìtope de glicoproteìna codificada pelo vìrus da imunodeficiência felina inativo - Google Patents
Anticorpo monoclonal especìfico para um epìtope de glicoproteìna codificada pelo vìrus da imunodeficiência felina inativoInfo
- Publication number
- BR0303500A BR0303500A BR0303500-0A BR0303500A BR0303500A BR 0303500 A BR0303500 A BR 0303500A BR 0303500 A BR0303500 A BR 0303500A BR 0303500 A BR0303500 A BR 0303500A
- Authority
- BR
- Brazil
- Prior art keywords
- monoclonal antibody
- immunodeficiency virus
- feline immunodeficiency
- inactive
- antibody specific
- Prior art date
Links
- 241000713800 Feline immunodeficiency virus Species 0.000 title abstract 3
- 108090000288 Glycoproteins Proteins 0.000 title abstract 2
- 102000003886 Glycoproteins Human genes 0.000 title abstract 2
- 101710121417 Envelope glycoprotein Proteins 0.000 abstract 1
- 108010052285 Membrane Proteins Proteins 0.000 abstract 1
- 102000018697 Membrane Proteins Human genes 0.000 abstract 1
- 102100021696 Syncytin-1 Human genes 0.000 abstract 1
- 235000004252 protein component Nutrition 0.000 abstract 1
- 229960005486 vaccine Drugs 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/08—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from viruses
- C07K16/10—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from viruses from RNA viruses
- C07K16/1036—Retroviridae, e.g. leukemia viruses
- C07K16/1045—Lentiviridae, e.g. HIV, FIV, SIV
- C07K16/1063—Lentiviridae, e.g. HIV, FIV, SIV env, e.g. gp41, gp110/120, gp160, V3, PND, CD4 binding site
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
Abstract
"ANTICORPO MONOCLONAL ESPECìFICO PARA UM EPìTOPE DE GLICOPROTEìNA CODIFICADA PELO VìRUS DA IMUNODEFICIêNCIA FELINA INATIVADO". A presente invenção fornece um anticorpo monocional específico para um epítope que é único para o componente de proteína superficial de uma glicoproteína do envelope do vírus da imunodeficiência felina (FIV) inativado. O referido anticorpo é útil para a quantificação de FIV inativado ou para a determinação da potência de uma vacina de FIV inativado.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US41024602P | 2002-09-12 | 2002-09-12 |
Publications (2)
Publication Number | Publication Date |
---|---|
BR0303500A true BR0303500A (pt) | 2004-09-08 |
BR0303500B1 BR0303500B1 (pt) | 2013-09-17 |
Family
ID=31888412
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
BRPI0303500-0B1A BR0303500B1 (pt) | 2002-09-12 | 2003-09-10 | anticorpo monoclonal específico para um epítopo de glicoproteína codificada pelo vírus da imunodeficiência felina (fiv) inativado, linhagens de células e métodos para determinar a potência e quantidade de fiv, bem como para detectar um epítopo para glicoproteína codificada por fiv. |
Country Status (22)
Country | Link |
---|---|
US (1) | US7345152B2 (pt) |
EP (2) | EP1398325B1 (pt) |
JP (1) | JP4472298B2 (pt) |
KR (1) | KR101114268B1 (pt) |
CN (1) | CN1528791B (pt) |
AR (1) | AR041230A1 (pt) |
AT (1) | ATE553126T1 (pt) |
AU (2) | AU2003246049A1 (pt) |
BR (1) | BR0303500B1 (pt) |
CO (1) | CO5500021A1 (pt) |
CY (1) | CY1112710T1 (pt) |
DK (1) | DK1398325T3 (pt) |
ES (1) | ES2383075T3 (pt) |
HR (1) | HRP20030729A2 (pt) |
MX (1) | MXPA03008083A (pt) |
NZ (1) | NZ528160A (pt) |
PL (1) | PL362164A1 (pt) |
PT (1) | PT1398325E (pt) |
RS (1) | RS51739B (pt) |
SI (1) | SI1398325T1 (pt) |
TW (1) | TW200406421A (pt) |
ZA (1) | ZA200307119B (pt) |
Families Citing this family (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP1624785B1 (en) * | 2003-01-17 | 2013-07-17 | Aethlon Medical, Inc. | Method for removal of viruses from blood by lectin affinity hemodialysis |
CN102735853B (zh) * | 2012-06-07 | 2014-06-04 | 广州市华南农大生物药品有限公司 | 一种猪流感灭活疫苗的效价测定方法 |
CN108473539B (zh) * | 2015-12-23 | 2022-03-22 | 英特维特国际股份有限公司 | 猫杯状病毒疫苗 |
CN110501509A (zh) * | 2019-09-03 | 2019-11-26 | 长春西诺生物科技有限公司 | 一种抗猫细小病毒猫源化基因工程抗体elisa试剂盒及其检测方法 |
Family Cites Families (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CA1341439C (en) * | 1987-08-26 | 2003-09-23 | Niels C. Pedersen | Feline t-lymphotropic lentivirus |
US6107077A (en) * | 1987-08-26 | 2000-08-22 | Yamamoto; Janet K. | Feline lymphoid cell lines capable of producing FIV for FIV diagnostics and vaccines |
US5177014A (en) * | 1988-12-05 | 1993-01-05 | Idexx Laboratories, Inc. | Monoclonal antibodies to feline-T-lymphotropic lentivirus |
US5219725A (en) | 1988-12-05 | 1993-06-15 | Idexx Laboratories Incorporated | Monoclonal antibodies to feline-t-lymphotropic lentivirus |
US6228608B1 (en) | 1991-02-28 | 2001-05-08 | Aquila Biopharmaceuticals, Inc. | Recombinant FIV glycoprotein 160 and P24 gag protein |
GB9215233D0 (en) | 1992-07-17 | 1992-09-02 | Pitman Moore Inc | Vaccines |
WO1994020622A1 (en) | 1993-03-11 | 1994-09-15 | Akzo Nobel N.V. | Polypeptide fragment capable of inducing neutralising antibodies against feline immuno-deficiency virus |
US6015686A (en) * | 1993-09-15 | 2000-01-18 | Chiron Viagene, Inc. | Eukaryotic layered vector initiation systems |
US6254872B1 (en) | 1995-08-25 | 2001-07-03 | University Of Florida | Multi-subtype FIV vaccines |
EP0997529B1 (en) | 1998-08-24 | 2005-12-21 | Pfizer Products Inc. | Feline immunodeficiency virus strain FIV-141 and uses thereof |
-
2003
- 2003-08-26 US US10/648,667 patent/US7345152B2/en not_active Expired - Lifetime
- 2003-09-08 KR KR1020030062762A patent/KR101114268B1/ko not_active IP Right Cessation
- 2003-09-08 MX MXPA03008083A patent/MXPA03008083A/es active IP Right Grant
- 2003-09-09 CO CO03078836A patent/CO5500021A1/es not_active Application Discontinuation
- 2003-09-10 ES ES03255660T patent/ES2383075T3/es not_active Expired - Lifetime
- 2003-09-10 EP EP03255660A patent/EP1398325B1/en not_active Expired - Lifetime
- 2003-09-10 JP JP2003318535A patent/JP4472298B2/ja not_active Expired - Fee Related
- 2003-09-10 SI SI200332137T patent/SI1398325T1/sl unknown
- 2003-09-10 AT AT03255660T patent/ATE553126T1/de active
- 2003-09-10 EP EP10183768A patent/EP2281838A1/en not_active Withdrawn
- 2003-09-10 BR BRPI0303500-0B1A patent/BR0303500B1/pt not_active IP Right Cessation
- 2003-09-10 DK DK03255660.7T patent/DK1398325T3/da active
- 2003-09-10 PT PT03255660T patent/PT1398325E/pt unknown
- 2003-09-11 AU AU2003246049A patent/AU2003246049A1/en not_active Abandoned
- 2003-09-11 HR HR20030729A patent/HRP20030729A2/xx not_active Application Discontinuation
- 2003-09-11 ZA ZA2003/07119A patent/ZA200307119B/en unknown
- 2003-09-11 AR ARP030103289A patent/AR041230A1/es active IP Right Grant
- 2003-09-11 NZ NZ528160A patent/NZ528160A/en not_active IP Right Cessation
- 2003-09-11 CN CN031649092A patent/CN1528791B/zh not_active Expired - Fee Related
- 2003-09-12 RS YU71803A patent/RS51739B/sr unknown
- 2003-09-12 TW TW092125182A patent/TW200406421A/zh unknown
- 2003-09-12 PL PL03362164A patent/PL362164A1/xx unknown
-
2010
- 2010-09-22 AU AU2010224370A patent/AU2010224370B2/en not_active Expired
-
2012
- 2012-05-03 CY CY20121100411T patent/CY1112710T1/el unknown
Also Published As
Publication number | Publication date |
---|---|
AU2010224370A1 (en) | 2010-10-14 |
BR0303500B1 (pt) | 2013-09-17 |
US20040053224A1 (en) | 2004-03-18 |
CN1528791A (zh) | 2004-09-15 |
CN1528791B (zh) | 2012-09-05 |
TW200406421A (en) | 2004-05-01 |
ATE553126T1 (de) | 2012-04-15 |
EP2281838A1 (en) | 2011-02-09 |
AU2010224370B2 (en) | 2011-07-21 |
YU71803A (sh) | 2006-05-25 |
MXPA03008083A (es) | 2004-11-29 |
SI1398325T1 (sl) | 2012-06-29 |
PL362164A1 (en) | 2004-03-22 |
JP4472298B2 (ja) | 2010-06-02 |
NZ528160A (en) | 2005-07-29 |
AU2003246049A1 (en) | 2004-04-01 |
ES2383075T3 (es) | 2012-06-18 |
EP1398325A1 (en) | 2004-03-17 |
JP2004097225A (ja) | 2004-04-02 |
PT1398325E (pt) | 2012-05-29 |
CO5500021A1 (es) | 2005-03-31 |
HRP20030729A2 (en) | 2005-02-28 |
DK1398325T3 (da) | 2012-05-21 |
KR20040024490A (ko) | 2004-03-20 |
US7345152B2 (en) | 2008-03-18 |
EP1398325B1 (en) | 2012-04-11 |
KR101114268B1 (ko) | 2012-03-05 |
ZA200307119B (en) | 2005-05-25 |
AR041230A1 (es) | 2005-05-11 |
RS51739B (sr) | 2011-10-31 |
CY1112710T1 (el) | 2016-02-10 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EE200700052A (et) | Antikeha he v?i mitme apo-lipoproteiin B fragmendi vastu | |
HUP0402192A2 (hu) | EGF receptor elleni antitesteket tartalmazó liofilizált készítmény | |
BRPI0510928A (pt) | identificação de organismos viralmente infectados e vacinados | |
BR0316670A (pt) | Anticorpos quiméricos e humanizados para integrina (alfa)5ß1 que modulam a angiogênese | |
AR063780A2 (es) | Un anticuerpo aislado composicion farmaceutica que lo comprende y metodo para inhibir la actividad de y detectar una interleuquina | |
BRPI0513237A (pt) | hidrolisados de proteìna para diminuição de pressão sanguìnea | |
CY1110634T1 (el) | Μεθοδοι προληψης και θεραπειας της νοσου του αλτσχαϊμερ (ad) | |
BR0308585A (pt) | Anticorpos anti-alfavbeta6 | |
ECSP045300A (es) | Antígenos virales | |
ATE417275T1 (de) | Puffern zur stabilizierung von hcv antigenen | |
BR0112026A (pt) | Anticorpos com dupla especificidade e métodos de produção e uso | |
ATE556717T1 (de) | Neutralisierung monoklonaler antikörper gegen mit schwerem akutem respirationssyndrom assoziiertem coronavirus | |
NO20001238D0 (no) | Monoklonalt antistoff som induserer apoptose | |
BR9912702A (pt) | Composto e método para a prevenção e/ou para o tratamento de alergias | |
ES2074062T3 (es) | Inmunoensayo para antigenos hiv-1 que utilizan fragmentos de f(ab')2 como sonda. | |
ES2066887T3 (es) | Anticuerpo monoclonal para diferenciar individuos seropositivos hiv-2 de los hiv-1. | |
ATE464374T1 (de) | Assay zum schnellen nachweis vom humanen aktivierten protein c und hochspezifischer monoklonaler antikörper dagegen | |
NO20044051L (no) | Analyse for ACTRIIB-kinase aktivitet | |
BR112021016619A2 (pt) | Anticorpo capaz de se ligar à calreticulina mutante de forma clivada e agente de diagnóstico, profilático ou terapêutico para neoplasmas mieloproliferativos | |
BR0113213A (pt) | Método para diagnosticar uma doença auto-imune, anticorpo, composição de diagnóstico, e, uso do anticorpo | |
NO20051715L (no) | HCV assay | |
BR0112497A (pt) | Antìgenos de streptococcus pyogenes | |
BR0303500A (pt) | Anticorpo monoclonal especìfico para um epìtope de glicoproteìna codificada pelo vìrus da imunodeficiência felina inativo | |
BR0312808A (pt) | Proteìna de fusão igg fc/hiv-gp120/c3d | |
BR112022001693A2 (pt) | Construtos de proteína de ligação ao antígeno e usos dos mesmos |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
B03H | Publication of an application: rectification [chapter 3.8 patent gazette] | ||
B06F | Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette] | ||
B06A | Patent application procedure suspended [chapter 6.1 patent gazette] | ||
B09A | Decision: intention to grant [chapter 9.1 patent gazette] | ||
B16A | Patent or certificate of addition of invention granted [chapter 16.1 patent gazette] |
Free format text: PRAZO DE VALIDADE: 10 (DEZ) ANOS CONTADOS A PARTIR DE 17/09/2013, OBSERVADAS AS CONDICOES LEGAIS. |
|
B25D | Requested change of name of applicant approved | ||
B25A | Requested transfer of rights approved | ||
B25D | Requested change of name of applicant approved | ||
B21F | Lapse acc. art. 78, item iv - on non-payment of the annual fees in time |
Free format text: REFERENTE A 13A ANUIDADE. |
|
B24J | Lapse because of non-payment of annual fees (definitively: art 78 iv lpi, resolution 113/2013 art. 12) |
Free format text: EM VIRTUDE DA EXTINCAO PUBLICADA NA RPI 2385 DE 20-09-2016 E CONSIDERANDO AUSENCIA DE MANIFESTACAO DENTRO DOS PRAZOS LEGAIS, INFORMO QUE CABE SER MANTIDA A EXTINCAO DA PATENTE E SEUS CERTIFICADOS, CONFORME O DISPOSTO NO ARTIGO 12, DA RESOLUCAO 113/2013. |